Endometrial Receptivity Assay (ERA) evaluates the development of endometrial lining in uterus through gene expression analysis to accept an embryo. Recent advances in genomic technologies allow analyzing the expression of 236 candidate genes to determine the optimal time to place an embryo into the uterus to increases the possibilities of successful implantation and pregnancy.
The ERA test is recommended for mothers with recurrent
implantation failure
